戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 egradation by enzymes such as neprilysin and insulin degrading enzyme.
2 mechanisms, including elevated expression of insulin-degrading enzyme.
3 ulin clearance due to down-regulation of the insulin-degrading enzyme.
4  of two endopeptidases, neprilysin (NEP) and insulin-degrading enzyme.
5 ecursor protein, presenilin 1, neprylisin or insulin-degrading enzyme.
6 retion and by inhibiting its degradation via insulin-degrading enzyme.
7 onstrated this activity can be attributed to insulin degrading enzyme, a previously described member
8 olytic degradation of monomeric Abeta by the insulin-degrading enzyme, a major Abeta-degrading enzyme
9 lar ADDLs applied to cells via seemingly the insulin-degrading enzyme activity.
10 TNF-alpha directly reduced the expression of insulin degrading enzyme and chaperone molecules (heat s
11 activities of other Abeta-degrading enzymes, insulin degrading enzyme and neprilysin, were unchanged.
12 e zinc-dependent insulin-degrading proteases insulin-degrading enzyme and cathepsin D were impaired;
13 minal fragment, and Abeta-degrading enzymes (insulin-degrading enzyme and neprilysin) in APP/CCL2 and
14 transition metal is an essential cofactor in insulin-degrading enzyme and several key Zn2+ finger tra
15 AD) markers, synaptophysin, APP, neprilysin, insulin-degrading enzyme and transthyretin in MCAT, Abet
16 nt of mRNA/protein changes in neprilysin and insulin-degrading enzyme and, instead, may involve neuro
17 ned, including endothelin-converting enzyme, insulin-degrading enzyme, and neprilysin.
18 e endothelin-converting enzymes, neprilysin, insulin-degrading enzyme, and plasmin.
19                                   A role for insulin-degrading enzyme as both a beta-endorphin-proces
20 e-2 diabetes, and the identification of IDE (insulin-degrading enzyme) as a diabetes susceptibility g
21                   The steady-state levels of insulin-degrading enzyme did not change significantly, w
22 metabolism and alternate processing, such as insulin degrading enzyme, endothelin-converting enzyme-1
23                         Cysteine residues in insulin degrading enzyme have been reported as non-criti
24 sed gamma-secretase activities and decreased insulin degrading enzyme (IDE) activities.
25 0 and Abeta42) with the fully active form of insulin degrading enzyme (IDE) through unrestrained, all
26 nverting the twelve cysteine residues in rat insulin degrading enzyme (IDE) to serines resulted in a
27                                              Insulin degrading enzyme (IDE) utilizes a large catalyti
28      Reduction of cell surface expression of insulin degrading enzyme (IDE), which cleaves the C-term
29 bled vimentin/nestin complexes interact with insulin degrading enzyme (IDE).
30                                              Insulin-degrading enzyme (IDE) (insulysin) is a zinc met
31 increase in NO results in S-nitrosylation of insulin-degrading enzyme (IDE) and dynamin-related prote
32 Previously, we showed that gE interacts with insulin-degrading enzyme (IDE) and facilitates VZV infec
33 hat they result in altered expression of the insulin-degrading enzyme (Ide) and fibroblast growth fac
34                  Recent reports suggest that insulin-degrading enzyme (IDE) and neutral endopeptidase
35                                              Insulin-degrading enzyme (IDE) can degrade insulin and a
36                                    Mammalian insulin-degrading enzyme (IDE) cleaves insulin, among ot
37                                              Insulin-degrading enzyme (IDE) exists primarily as a dim
38 cently found that homozygous deletion of the insulin-degrading enzyme (IDE) gene in mice results in a
39                                              Insulin-degrading enzyme (IDE) has been implicated as a
40                                              Insulin-degrading enzyme (IDE) hydrolyzes bioactive pept
41                  We investigated the role of insulin-degrading enzyme (IDE) in amylin degradation, am
42                                  Deletion of insulin-degrading enzyme (IDE) in mice causes accumulati
43                  Recent studies suggest that insulin-degrading enzyme (IDE) in neurons and microglia
44                                We found that insulin-degrading enzyme (IDE) interacts with gE through
45                                              Insulin-degrading enzyme (IDE) is a component of a cytos
46                                              Insulin-degrading enzyme (IDE) is a highly conserved zin
47                                              Insulin-degrading enzyme (IDE) is a protease that cleave
48                                              Insulin-degrading enzyme (IDE) is a ubiquitous zinc-meta
49                                              Insulin-degrading enzyme (IDE) is a zinc metalloprotease
50                                              Insulin-degrading enzyme (IDE) is a zinc metalloprotease
51                                              Insulin-degrading enzyme (IDE) is an atypical zinc-metal
52                                              Insulin-degrading enzyme (IDE) is identified as such a p
53                                              Insulin-degrading enzyme (IDE) is involved in the cleara
54                                              Insulin-degrading enzyme (IDE) is one of the proteins th
55  involved in mitAbeta catabolism is the long insulin-degrading enzyme (IDE) isoform (IDE-Met(1)).
56                  Recent reports suggest that insulin-degrading enzyme (IDE) may have specificity for
57 re we show that transgenic overexpression of insulin-degrading enzyme (IDE) or neprilysin (NEP) in ne
58 a hormone vital for glucose homeostasis, and insulin-degrading enzyme (IDE) plays a key role in its c
59                                              Insulin-degrading enzyme (IDE) selectively degrades the
60 ves gamma-secretase activation and decreased insulin-degrading enzyme (IDE) steady-state levels in a
61                                              Insulin-degrading enzyme (IDE) was found to rapidly clea
62  and the active site histidine (His(112)) of insulin-degrading enzyme (IDE) were mutated.
63                                              Insulin-degrading enzyme (IDE), a 110-kDa metalloendopep
64 e and find that it is indistinguishable from insulin-degrading enzyme (IDE), a thiol metalloendopepti
65                                              Insulin-degrading enzyme (IDE), a Zn2+-metalloprotease,
66                            Two substrates of insulin-degrading enzyme (IDE), amyloid beta-protein (Ab
67 main that interacts with a putative receptor insulin-degrading enzyme (IDE), replicated as extensivel
68 cated in the non-coding region (intron 1) of insulin-degrading enzyme (IDE), was the most strongly as
69 genetic system for functional studies of the insulin-degrading enzyme (IDE), which cleaves and inacti
70 terminal region also mediates binding to the insulin-degrading enzyme (IDE), which is proposed to be
71     One candidate gene in this region is the insulin-degrading enzyme (IDE), which, in the GK rat mod
72                              The rate of the insulin-degrading enzyme (IDE)-catalyzed hydrolysis of t
73 grading enzymes such as neprilysin (NEP) and insulin-degrading enzyme (IDE).
74 fter purification, is indistinguishable from insulin-degrading enzyme (IDE).
75                                              Insulin-degrading enzyme (IDE, insulysin) is the best ch
76 adation in MDM is sensitive to lysosomal and insulin degrading enzyme inhibitors but insensitive to p
77 panning the 5' untranslated region region of insulin-degrading enzyme is associated with serum cotini
78 ilarly, Abeta degradation extracellularly by insulin-degrading enzyme is facilitated by ApoE.
79          Each of the ICDs are degraded by an insulin degrading enzyme-like activity, but they can be
80 l new biomarkers, a P. falciparum homolog of insulin-degrading enzyme (PfIDEh) met our search criteri
81 r sites as wild-type Abeta by neprilysin and insulin-degrading enzyme, the two most widely studied Ab
82 o a 1-h incubation with either neprilysin or insulin degrading enzyme, whereas the monomer is rapidly
83              Pretreatment of the medium with insulin-degrading enzyme, which degrades Abeta monomers
84 rotease Ste23 in yeast, a homologue of human insulin-degrading enzyme, which is required for efficien

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。